Publication | Closed Access

A prospective, randomized controlled trial comparing the efficacy and safety of Sotalol, Amiodarone, and Digoxin for the reversion of new-onset atrial fibrillation

New-onset Atrial FibrillationCardiovascular DiseaseMedicineCardiovascular PharmacologyPharmacotherapyAcute Myocardial InfarctionAtrial FibrillationPublic HealthPharmacologyAnticoagulantCardiologyAnesthesiology